Noaga Ily
Research Subjects
Research Interests
Noaga Ily has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Abdoulaye Hama Diallo
Université Joseph KI-ZERBO
1 shared publication - Augustin Nawidimbasba Zeba
Unité de Nutrition, Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), 399, Avenue de la Liberté, 01 BP 545, Bobo-Dioulasso, Burkina Faso
1 shared publication - Hermann Biénou Lanou
Centre National de la Recherche Scientifique et Technologique (CNRST)
1 shared publication - Jeoffray Diendéré
Unité de Nutrition, Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), 399, Avenue de la Liberté, 01 BP 545, Bobo-Dioulasso, Burkina Faso
1 shared publication - Sibiri Konate
Ministry of Health-Hauts-Bassins Regional Health Directorate, Medical Center with Surgical Unit in Dafra, Bobo-Dioulasso, Burkina Faso
1 shared publication - Watton Rodrigue Diao
Centre des Opérations de Réponse aux Urgences Sanitaires (CORUS), Institut National de Santé Publique (INSP), Bobo-Dioulasso 01 BP 1500, Burkina Faso
1 shared publication
Latest Publications
- Open Access
- 8 September 2025
- Published by Science Publishing Group in Central African Journal of Public Health
- Vol. 11 (5) , 299-310
Estimating Direct Cost for Hypertension Management in Urban Primary Health Facilities in Bobo-Dioulasso, Burkina Faso: A Patient-Level Analysis
Introduction : Hypertension is among the top 10 reasons for visiting primary health care centres (PHCCs) in Burkina Faso. Using a patient-level analysis, this study estimated the direct cost for hypertension management at outpatient care, in urban PHCCs in Bobo-Dioulasso, in the context of a universal health coverage policy development in the country. Methods : This was a cross-sectional study, using an adapted form of the “Costs for Patients Questionnaire” (CoPaQ) that includes different components for direct cost estimations. A sample of 380 hypertensive adults were interviewed from January to February 2022, at 20 public PHCCs in Bobo-Dioulasso. Results : Per patient-year, the means [95% CI] in income and direct cost were 786 947 CFA (USD 1418.3) [694 200 (USD 1251.1) - 879 695 (USD 1585.4)] and 78 623 FCFA (USD 141.3) [68 766 (124.0) - 88 480 (159.5)], respectively. Of the annual total direct cost, 47.5%, 18.5%, 16.3% and 13.5% were spent on medication, medical visits, hospitalisations and paraclinical tests, respectively. Only two patients (0.5%) were enrolled in insurance policy; and uncontrolled hypertension frequency was 72.1% (95% CI: 67.3-76.6). Conclusion : The average direct cost per patient-year of managing hypertension exceeded one-tenth of the patient's annual income, equivalent to more than one-fifth of the country's guaranteed minimum wage, which is a significant financial burden for many people. This study should be followed by cost-effectiveness analyses and community engagement building for hypertension control at small-scale piloting in Bobo-Dioulasso, then broad-based in the country.
- 8 September 2025
- Published by Science Publishing Group in Central African Journal of Public Health
- Vol. 11 (5) , 299-310
Open AccessEstimating Direct Cost for Hypertension Management in Urban Primary Health Facilities in Bobo-Dioulasso, Burkina Faso: A Patient-Level Analysis
Introduction : Hypertension is among the top 10 reasons for visiting primary health care centres (PHCCs) in Burkina Faso. Using a patient-level analysis, this study estimated the direct cost for hypertension management at outpatient care, in urban PHCCs in Bobo-Dioulasso, in the context of a universal health coverage policy development in the country. Methods : This was a cross-sectional study, using an adapted form of the “Costs for Patients Questionnaire” (CoPaQ) that includes different components for direct cost estimations. A sample of 380 hypertensive adults were interviewed from January to February 2022, at 20 public PHCCs in Bobo-Dioulasso. Results : Per patient-year, the means [95% CI] in income and direct cost were 786 947 CFA (USD 1418.3) [694 200 (USD 1251.1) - 879 695 (USD 1585.4)] and 78 623 FCFA (USD 141.3) [68 766 (124.0) - 88 480 (159.5)], respectively. Of the annual total direct cost, 47.5%, 18.5%, 16.3% and 13.5% were spent on medication, medical visits, hospitalisations and paraclinical tests, respectively. Only two patients (0.5%) were enrolled in insurance policy; and uncontrolled hypertension frequency was 72.1% (95% CI: 67.3-76.6). Conclusion : The average direct cost per patient-year of managing hypertension exceeded one-tenth of the patient's annual income, equivalent to more than one-fifth of the country's guaranteed minimum wage, which is a significant financial burden for many people. This study should be followed by cost-effectiveness analyses and community engagement building for hypertension control at small-scale piloting in Bobo-Dioulasso, then broad-based in the country.